Table 3.
Malignancy associated hypercalcemia in KSC patients: Core demographic and laboratory findings. No (%): Number (% cases with available data).
| Demographics | ||
|---|---|---|
| Age, median [range], y | 58 [5–83] | |
| Sex, No (%) | Women | 5 (16) |
| Men | 27 (84) | |
| Tumor, No (%) | SCC | 30 (94) |
| Other | 2 (6) | |
| Laboratory findings | ||
| Hypercalcemia a , Νο (%) | mild | 4 (13) |
| moderate | 9 (28) | |
| severe | 19 (59) | |
| Phosphorus b , Νο (%) | decreased | 5 (25) |
| norm | 14 (70) | |
| increased | 1 (5) | |
| N/A | 12 (38) | |
| Parathormone b , PTH, Νο (%) | decreased | 15 (54) |
| norm | 13 (46) | |
| increased | 0 (0) | |
| N/A | 4 (12) | |
| Parathormone related protein, PTHrP b, Νο (%) | decreased | 0 (0) |
| norm | 1 (5) | |
| increased | 20 (95) | |
| N/A | 11 (34) | |
| Vitamin D3 b, No (%) | decreased | 5 (31) |
| norm | 10 (63) | |
| increased | 1 (6) | |
| N/A | 16 (50) |
The background color highlights the data that refer to one factor. a Mild: 10.7—11.9 mg/dL; moderate: 12.0–13.9 mg/dL; severe: ≥14 mg/dL. b Explanations. norm: within normal range; increased: above norm range; decreased: below norm range; N/A: value not available. Abbreviations. D3: 1,25 (OH)2 D3; KSC: Keratinocyte Skin Cancer; PLM: pilomatrixoma; PTH: parathormone; PTHrP: parathormone related protein; SCC: cutaneous Squamous Cell Carcinoma; TRC: trichilemmal carcinoma.